Picture of Oncoinvent ASA logo

ONCIN — Oncoinvent ASA News Story

0.000.00%
no flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapMomentum Trap

Brief: BerGenBio Contemplates Private Placement

May 4 (Reuters) - Bergenbio ASA  BGBIO.OL :
    * CONTEMPLATED PRIVATE PLACEMENT
    * COMPANY HAS RETAINED ARCTIC SECURITIES AS, CARNEGIE AS AND
DNB
MARKETS, A PART OF DNB BANK ASA AS JOINT BOOKRUNNERS
    * CONTEMPLATED PRIVATE PLACEMENT OF UP TO NOK 500 MILLION BY
ISSUANCE OF UP TO 13,325,000 SHARES, REPRESENTING APPROX. 18% OF
OUTSTANDING SHARE CAPITAL OF COMPANY
    * COMPANY INTENDS TO USE NET PROCEEDS FROM PRIVATE PLACEMENT
TO
TAKE FULL ADVANTAGE OF CLINICAL DEVELOPMENT OPPORTUNITIES
STEMING FROM COMPANY'S TECHNOLOGY AND TO PROGRESS READINESS FOR
EARLY COMMERCIALISATION POSSIBILITIES
    * SUBSCRIPTION PRICE WILL BE DETERMINED BY BOARD OF
DIRECTORS OF
COMPANY ( "BOARD") BASED ON AN ACCELERATED BOOKBUILDING PROCESS

Source text for Eikon:  ID:nWkr47h2Pn 
Further company coverage:  BGBIO.OL 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Oncoinvent ASA

See all news